HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model
A. McNaughton, J. Lourenco, L. Hattingh, E. Adland, S. Daniels, A. van Zyl, C. S. Akiror, S. Wareing, K. Jeffery, A. Ansari, P. Klenerman, P. Goulder, S. Gupta, P. Jooste, P. C. Matthews
This study evaluates HBV vaccination and PMTCT as tools for elimination in HIV-coinfected populations using a clinical cohort and dynamic model, showing potential for significant public health impact by 2030.
bioRxiv · Sep 24, 2018Microbiology